আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
ceftriaxona normon stungulyfs-/innrennslisstofn og leysir, lausn 1000 mg
laboratorios normon, s.a. - ceftriaxonum dínatríum - stungulyfs-/innrennslisstofn og leysir, lausn - 1000 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
doxylin tafla 100 mg
actavis group ptc ehf. - doxycyclinum inn - tafla - 100 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
doxycyklin eql pharma tafla 100 mg
eql pharma ab - doxycyclinum inn - tafla - 100 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
ringer-acetat baxter viaflo innrennslislyf, lausn
baxter medical ab* - natrii chloridum; kalii chloridum; calcium chloride; magnesii chloridum; natrii acetas - innrennslislyf, lausn
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
decortin h tafla 5 mg
merck ab - prednisolonum inn - tafla - 5 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
oracea hart hylki með breyttan losunarhraða 40 mg
galderma nordic ab - doxycyclinum inn - hart hylki með breyttan losunarhraða - 40 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
ciprofloxacin navamedic (ciprofloxacin villerton) innrennslislyf, lausn 2 mg/ml
navamedic asa - ciprofloxacinum laktat - innrennslislyf, lausn - 2 mg/ml
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
marcain adrenalin stungulyf, lausn 2,5 mg/ml+5 míkróg/m
aspen pharma trading limited - bupivacainum hýdróklóríð; adrenalinum bítartrat (epinephrinum bítartrat) - stungulyf, lausn - 2,5 mg/ml+5 míkróg/m
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
marcain adrenalin stungulyf, lausn 5 mg/ml+5 míkróg/ml
aspen pharma trading limited - bupivacainum hýdróklóríð; adrenalinum bítartrat (epinephrinum bítartrat) - stungulyf, lausn - 5 mg/ml+5 míkróg/ml
ইউরোপীয় ইউনিয়ন -
আইসল্যান্ডীয় -
EMA (European Medicines Agency)
fluenz
medimmune llc - reassortant inflúensu veira (lifandi, bæklaða) eftir stofnar:a/kaliforníu/7/2009 (h1n1)pdm09 eins og stofn, a/victoria/361/2011 (h3n2) eins og stofn, b/massachusetts/2/2012 eins og álag - influenza, human; immunization - bóluefni - fyrirbyggjandi meðferð inflúensu hjá einstaklingum 24 mánaða til yngri en 18 ára. notkun fluenz ætti að vera byggt á opinberum tillögur.